Sign Up to like & get
recommendations!
0
Published in 2017 at "Psychiatric Quarterly"
DOI: 10.1007/s11126-017-9515-x
Abstract: Clozapine is the sole antipsychotic agent effective for the treatment of refractory schizophrenia. Sixty percent of clozapine-treated patients, however, fail to adequately respond. Minocycline, a tetracycline antibiotic, possesses antiinflammatory and neuroprotective properties that may play…
read more here.
Keywords:
plasma levels;
minocycline clozapine;
clozapine plasma;
clozapine ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000001657
Abstract: Abstract Background It is unknown whether increasing the clozapine plasma level to 400, 750, or even 1000 ng/mL is a feasible and effective strategy in patients with treatment-resistant schizophrenia (TRS). We investigated this in long-stay…
read more here.
Keywords:
clozapine plasma;
long stay;
clozapine;
patients treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s205205
Abstract: [This corrects the article on p. 1535 in vol. 14, PMID: 29950838.].
read more here.
Keywords:
dose gender;
smoking clozapine;
cigarette smoking;
clozapine plasma ... See more keywords